UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-KSB
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the Fiscal Year Ended December 31, 1996
Commission File Number 2-96271-B
CAS MEDICAL SYSTEMS, INC.
(Name of Small Business Issuer as specified in its charter)
Delaware 06-1123096
(State or other jurisdiction of (I.R.S. Employer Identification
No.)
incorporation or organization)
21 Business Park Drive
Branford, Connecticut 06405
(Address of principal executive offices) (Zip code)
Issuer's telephone number, including area code: (203) 488-6056
Securities registered under Section 12(b) of the Exchange Act:
None
Securities registered under Section 12(g) of the Exchange Act:
Title_of_Each_Class
Units
Common Stock, $.004 par value
Preferred Stock $.001 par value
Check whether the issuer (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act during the past 12
months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the
past 90 days. Yes [X] No [ ]
Check if there is no disclosure of delinquent filers in response to Item
405 of Regulation S-B contained in this form and no disclosure will be
contained, to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this form
10-KSB or any amendment to this form 10-KSB [X]
The aggregate market value of voting stock held by non-affiliates of the
Registrant as of December 31, 1996 was based upon the last sale price of
such stock on that date as reported by the NASDAQ SmallCapSM Market was
7,162,996. The number of shares of the Registrant's common Stock
outstanding as of December 31, 1996 was 9,329,277.
DOCUMENTS INCORPORATED BY REFERENCE:
Portions of registrant's Proxy Statement for its Annual Meeting of
Stockholders to be held on June 11, 1997 are incorporated by reference in
Part III of this Report. Except as expressly incorporated by reference,
registrant's Proxy Statement shall not be deemed to be part of this Form
10-KSB.
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.
CAS MEDICAL SYSTEMS, INC.
(Registrant)
March 25, 1997 Louis P. Scheps
Date Louis P. Scheps
President and Chief Executive Officer
and Chief Financial Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed by the following persons on behalf of the Registrant
and in the capacities and on the dates indicated.
March 25, 1997 Myron L. Cohen
Date Myron L. Cohen
Executive Vice President
March 25, 1997 Lawrence Burstein
Date Lawrence Burstein
Director
March 25, 1997 Jerome Baron
Date Jerome Baron
Director
March 25, 1997 Saul Milles
Date Saul Milles
Director
